STEVEN VICTOR O'NEIL

Person

EAST LYME, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 11,964,961
- Issue date Apr 23, 2024
- Pfizer Inc.
- Michael Aaron Brodney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 11,014,909
- Issue date May 25, 2021
- Pfizer Inc.
- Michael Aaron Brodney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic spiro compounds as MAGL inhibitors
- Patent number 10,858,373
- Issue date Dec 8, 2020
- Pfizer Inc.
- Michael Aaron Brodney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,...
- Patent number 10,723,711
- Issue date Jul 28, 2020
- Pfizer Inc.
- Christopher Ryan Butler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 10,696,658
- Issue date Jun 30, 2020
- Pfizer Inc.
- Michael Aaron Brodney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as MAGL...
- Patent number 10,626,125
- Issue date Apr 21, 2020
- Pfizer Inc.
- Michael Aaron Brodney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,...
- Patent number 10,428,034
- Issue date Oct 1, 2019
- Pfizer Inc.
- Christopher Ryan Butler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 10,421,744
- Issue date Sep 24, 2019
- Pfizer Inc.
- Michael Aaron Brodney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as MAGL...
- Patent number 10,329,308
- Issue date Jun 25, 2019
- Pfizer Inc.
- Michael Aaron Brodney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 10,093,655
- Issue date Oct 9, 2018
- Pfizer Inc.
- Michael Aaron Brodney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 10,077,272
- Issue date Sep 18, 2018
- Pfizer Inc.
- David Lawrence Firman Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,868,744
- Issue date Jan 16, 2018
- Pfizer Inc.
- David Lawrence Firman Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,...
- Patent number 9,845,301
- Issue date Dec 19, 2017
- Pfizer Inc.
- Christopher Ryan Butler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,822,097
- Issue date Nov 21, 2017
- Pfizer Inc.
- Michael Aaron Brodney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic compounds and their use as dopamine D1 ligands
- Patent number 9,745,317
- Issue date Aug 29, 2017
- Pfizer Inc.
- David Lawrence Firman Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,617,275
- Issue date Apr 11, 2017
- Pfizer Inc.
- Jotham Wadsworth Coe
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,527,831
- Issue date Dec 27, 2016
- Pfizer Inc.
- Michael Aaron Brodney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,527,843
- Issue date Dec 27, 2016
- Pfizer Inc.
- Jennifer Elizabeth Davoren
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,139,561
- Issue date Sep 22, 2015
- Pfizer Inc.
- Michael Aaron Brodney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,133,190
- Issue date Sep 15, 2015
- Pfizer Inc.
- Jennifer Elizabeth Davoren
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,107,923
- Issue date Aug 18, 2015
- Pfizer Inc.
- Michael Aaron Brodney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 8,822,494
- Issue date Sep 2, 2014
- Pfizer Inc.
- Jennifer Elizabeth Davoren
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR ANTAGONISTS A...
- Publication number 20240366598
- Publication date Nov 7, 2024
- Pfizer Inc.
- Kevin James Filipski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20240317713
- Publication date Sep 26, 2024
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HSD17B13 Inhibitors and/or Degraders
- Publication number 20240238425
- Publication date Jul 18, 2024
- Pfizer Inc.
- Jan Antoinette Cusi Romero Adams
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HSD17B13 INHIBITORS AND/OR DEGRADERS
- Publication number 20240150334
- Publication date May 9, 2024
- Pfizer Inc.
- Jan Antoinette Cusi Romero Adams
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heterocyclic Spiro Compounds As MAGL Inhibitors
- Publication number 20210309669
- Publication date Oct 7, 2021
- Pfizer Inc.
- Michael Aaron Brodney
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20210300899
- Publication date Sep 30, 2021
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20200283407
- Publication date Sep 10, 2020
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
1,1,1-TRIFLUORO-3-HYDROXYPROPAN-2-YL CARBAMATE DERIVATIVES AND 1,1,...
- Publication number 20190382359
- Publication date Dec 19, 2019
- Pfizer Inc.
- CHRISTOPHER RYAN BUTLER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20190367485
- Publication date Dec 5, 2019
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC SPIRO COMPOUNDS AS MAGL INHIBITORS
- Publication number 20190292203
- Publication date Sep 26, 2019
- Pfizer Inc.
- Michael Aaron Brodney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
1,1,1-TRIFLUORO-3-HYDROXYPROPAN-2-YL CARBAMATE DERIVATIVES AS MAGL...
- Publication number 20190276472
- Publication date Sep 12, 2019
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20190002439
- Publication date Jan 3, 2019
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20180346477
- Publication date Dec 6, 2018
- Pfizer Inc.
- DAVID LAWRENCE FIRMAN GRAY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC SPIRO COMPOUNDS AS MAGL INHIBITORS
- Publication number 20180208608
- Publication date Jul 26, 2018
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
1,1,1-TRIFLUORO-3-HYDROXYPROPAN-2-YL CARBAMATE DERIVATIVES AS MAGL...
- Publication number 20180208607
- Publication date Jul 26, 2018
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands
- Publication number 20180200253
- Publication date Jul 19, 2018
- Pfizer Inc.
- JOTHAM WADSWORTH COE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20180072750
- Publication date Mar 15, 2018
- Pfizer Inc.
- DAVID LAWRENCE FIRMAN GRAY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
1,1,1-TRIFLUORO-3-HYDROXYPROPAN-2-YL CARBAMATE DERIVATIVES AND 1,1,...
- Publication number 20180065943
- Publication date Mar 8, 2018
- Pfizer Inc.
- CHRISTOPHER RYAN BUTLER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20180037571
- Publication date Feb 8, 2018
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands
- Publication number 20170165270
- Publication date Jun 15, 2017
- Pfizer Inc.
- JOTHAM WADSWORTH COE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20170057947
- Publication date Mar 2, 2017
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20170044174
- Publication date Feb 16, 2017
- Pfizer Inc.
- DAVID LAWRENCE FIRMAN GRAY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20170037053
- Publication date Feb 9, 2017
- Pfizer Inc.
- DAVID LAWRENCE FIRMAN GRAY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
1,1,1-TRIFLUORO-3-HYDROXYPROPAN-2-YL CARBAMATE DERIVATIVES AND 1,1,...
- Publication number 20170029390
- Publication date Feb 2, 2017
- Pfizer Inc.
- CHRISTOPHER RYAN BUTLER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIDINE DERIVATIVES AS MUSCARINIC M1 RECEPTOR POSITIVE ALLOSTERIC...
- Publication number 20160016907
- Publication date Jan 21, 2016
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands
- Publication number 20150344490
- Publication date Dec 3, 2015
- Pfizer Inc.
- JOTHAM WADSWORTH COE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20150344474
- Publication date Dec 3, 2015
- Pfizer Inc.
- JENNIFER ELIZABETH DAVOREN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands
- Publication number 20150291625
- Publication date Oct 15, 2015
- Pfizer Inc.
- JOTHAM WADSWORTH COE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20150196561
- Publication date Jul 16, 2015
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20150175573
- Publication date Jun 25, 2015
- Pfizer Inc.
- MICHAEL AARON BRODNEY
- C07 - ORGANIC CHEMISTRY

STEVEN VICTOR O'NEIL

Person

Patents Grantslast 30 patents

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Heterocyclic spiro compounds as MAGL inhibitors

1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,...

Heteroaromatic compounds and their use as dopamine D1 ligands

1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as MAGL...

1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,...

Heteroaromatic compounds and their use as dopamine D1 ligands

1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as MAGL...

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,...

Heteroaromatic compounds and their use as dopamine D1 ligands

Heterocyclic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Patents Applicationslast 30 patents

GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR ANTAGONISTS A...

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

HSD17B13 Inhibitors and/or Degraders

HSD17B13 INHIBITORS AND/OR DEGRADERS

Heterocyclic Spiro Compounds As MAGL Inhibitors

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

1,1,1-TRIFLUORO-3-HYDROXYPROPAN-2-YL CARBAMATE DERIVATIVES AND 1,1,...

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

HETEROCYCLIC SPIRO COMPOUNDS AS MAGL INHIBITORS

1,1,1-TRIFLUORO-3-HYDROXYPROPAN-2-YL CARBAMATE DERIVATIVES AS MAGL...

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

HETEROCYCLIC SPIRO COMPOUNDS AS MAGL INHIBITORS

1,1,1-TRIFLUORO-3-HYDROXYPROPAN-2-YL CARBAMATE DERIVATIVES AS MAGL...

Heteroaromatic Compounds and their Use as Dopamine D1 Ligands

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

1,1,1-TRIFLUORO-3-HYDROXYPROPAN-2-YL CARBAMATE DERIVATIVES AND 1,1,...

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

Heteroaromatic Compounds and their Use as Dopamine D1 Ligands

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

HETEROCYCLIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

1,1,1-TRIFLUORO-3-HYDROXYPROPAN-2-YL CARBAMATE DERIVATIVES AND 1,1,...

PYRIDINE DERIVATIVES AS MUSCARINIC M1 RECEPTOR POSITIVE ALLOSTERIC...

Heteroaromatic Compounds and their Use as Dopamine D1 Ligands

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

Heteroaromatic Compounds and their Use as Dopamine D1 Ligands

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS